In three of five freshly dissected human glioblastomas, gene expression levels of Grm3 were higher in the CD133-positive GSC population than in CD133-negative non-GSCs, and Grm3 gene expression was overall higher than that of Grm2 (Figure S2C). The gene discussed is GRM2; the disease is glioblastoma.